276 related articles for article (PubMed ID: 23788674)
1. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification.
Nishihara R; Morikawa T; Kuchiba A; Lochhead P; Yamauchi M; Liao X; Imamura Y; Nosho K; Shima K; Kawachi I; Qian ZR; Fuchs CS; Chan AT; Giovannucci E; Ogino S
Am J Epidemiol; 2013 Jul; 178(1):84-100. PubMed ID: 23788674
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.
Limsui D; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
J Natl Cancer Inst; 2010 Jul; 102(14):1012-22. PubMed ID: 20587792
[TBL] [Abstract][Full Text] [Related]
3. A Prospective Study of Smoking and Risk of Synchronous Colorectal Cancers.
Drew DA; Nishihara R; Lochhead P; Kuchiba A; Qian ZR; Mima K; Nosho K; Wu K; Wang M; Giovannucci E; Fuchs CS; Chan AT; Ogino S
Am J Gastroenterol; 2017 Mar; 112(3):493-501. PubMed ID: 28117362
[TBL] [Abstract][Full Text] [Related]
4. Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.
Samadder NJ; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
Gastroenterology; 2013 Aug; 145(2):348-56.e1-2. PubMed ID: 23665275
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors and Incidence of Colorectal Cancer According to Major Molecular Subtypes.
Wang L; He X; Ugai T; Haruki K; Lo CH; Hang D; Akimoto N; Fujiyoshi K; Wang M; Fuchs CS; Meyerhardt JA; Zhang X; Wu K; Chan AT; Giovannucci EL; Ogino S; Song M
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442661
[TBL] [Abstract][Full Text] [Related]
6. Calcium intake and colon cancer risk subtypes by tumor molecular characteristics.
Keum N; Liu L; Hamada T; Qian ZR; Nowak JA; Cao Y; da Silva A; Kosumi K; Song M; Nevo D; Wang M; Chan AT; Meyerhardt JA; Fuchs CS; Wu K; Ogino S; Nishihara R; Zhang X
Cancer Causes Control; 2019 Jun; 30(6):637-649. PubMed ID: 30963391
[TBL] [Abstract][Full Text] [Related]
7. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.
Ogino S; Nosho K; Kirkner GJ; Kawasaki T; Meyerhardt JA; Loda M; Giovannucci EL; Fuchs CS
Gut; 2009 Jan; 58(1):90-6. PubMed ID: 18832519
[TBL] [Abstract][Full Text] [Related]
8. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability.
Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F
Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826
[TBL] [Abstract][Full Text] [Related]
10. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239
[TBL] [Abstract][Full Text] [Related]
11. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS
J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer.
Sanchez JA; Krumroy L; Plummer S; Aung P; Merkulova A; Skacel M; DeJulius KL; Manilich E; Church JM; Casey G; Kalady MF
Br J Surg; 2009 Oct; 96(10):1196-204. PubMed ID: 19787768
[TBL] [Abstract][Full Text] [Related]
14. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status.
Dahlin AM; Palmqvist R; Henriksson ML; Jacobsson M; Eklöf V; Rutegård J; Oberg A; Van Guelpen BR
Clin Cancer Res; 2010 Mar; 16(6):1845-55. PubMed ID: 20197478
[TBL] [Abstract][Full Text] [Related]
15. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.
Samowitz WS; Albertsen H; Sweeney C; Herrick J; Caan BJ; Anderson KE; Wolff RK; Slattery ML
J Natl Cancer Inst; 2006 Dec; 98(23):1731-8. PubMed ID: 17148775
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
[TBL] [Abstract][Full Text] [Related]
17. CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
Vedeld HM; Merok M; Jeanmougin M; Danielsen SA; Honne H; Presthus GK; Svindland A; Sjo OH; Hektoen M; Eknaes M; Nesbakken A; Lothe RA; Lind GE
Int J Cancer; 2017 Sep; 141(5):967-976. PubMed ID: 28542846
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype-high colorectal carcinoma.
Takashima Y; Kawamura H; Okadome K; Ugai S; Haruki K; Arima K; Mima K; Akimoto N; Nowak JA; Giannakis M; Garrett WS; Sears CL; Song M; Ugai T; Ogino S
Clin Microbiol Infect; 2024 May; 30(5):630-636. PubMed ID: 38266708
[TBL] [Abstract][Full Text] [Related]
19. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.
Mehta RS; Song M; Nishihara R; Drew DA; Wu K; Qian ZR; Fung TT; Hamada T; Masugi Y; da Silva A; Shi Y; Li W; Gu M; Willett WC; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
Gastroenterology; 2017 Jun; 152(8):1944-1953.e1. PubMed ID: 28249812
[TBL] [Abstract][Full Text] [Related]
20. Association Between Smoking and Molecular Subtypes of Colorectal Cancer.
Wang X; Amitay E; Harrison TA; Banbury BL; Berndt SI; Brenner H; Buchanan DD; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Gallinger SJ; Giannakis M; Giles GG; Gunter MJ; Hopper JL; Jenkins MA; Lin Y; Moreno V; Nishihara R; Newcomb PA; Ogino S; Phipps AI; Sakoda LC; Schoen RE; Slattery ML; Song M; Sun W; Thibodeau SN; Toland AE; Van Guelpen B; Woods MO; Hsu L; Hoffmeister M; Peters U
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
